Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TRAZODONE HYDROCHLORIDE USP, with a corresponding US DMF Number 32928.
Remarkably, this DMF maintains an Active status since its submission on August 31, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 16, 2018, and payment made on August 10, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II